When to start ART in Africa.
To the Editor:
In their Perspective article, De Cock and El-Sadr (March 7 issue)1 highlight the need for data on when to start antiretroviral therapy (ART) for HIV-infected people in Africa who have CD4+ counts above 350 cells per cubic millimeter. However, their proposed solution — a new randomized, controlled trial in Africa — is flawed.
- nejmc1304494.pdf application/pdf 304 KB Download File
Also Published In
- New England Journal of Medicine
More About This Work
- Academic Units
- International Center for AIDS Care and Treatment Programs
- Massachusetts Medical Society
- Published Here
- October 9, 2015